Published
2024-02-02
Section
Articles
How to Cite
Research on the Motivation of Financial Fraud in Chinese Pharmaceutical Industry-Taking Kangmei Pharmaceutical as an Example
Xinyi Zhang
Heilongjiang University
DOI: https://doi.org/10.59429/paat.v5i3.1384
Keywords: Pharmaceutical Industry; Financial Fraud; Fraud Motivation; Kangmei Pharmaceutical
Abstract
With the advancement of living standards and the continuous rise in demand for healthcare security, the pharmaceutical industry is poised for significant development. However, recent years have witnessed a concerning trend of financial misconduct among several publicly listed pharmaceutical companies in China. This unethical behavior has not only cast a shadow over the Chinese pharmaceutical market but also reverberated throughout the broader capital market. Consequently, an in-depth examination of the motivation of financial fraud within China's pharmaceutical sector holds profound importance.
References
[1] Basil AN. Corporate governance and CEO pay:Evidence from UK Travel and Leisure listed firms[J].Tourism Management, 2017, (60): 9-14. [2] Madan Lal Bhasin. Creative Accounting scam at satyam computer limited:How the fraud story unfolded?[J]. Open
Journal of Accounting, 2016, 05(04), 25. [3] Hong Y, Xu SB. Analysis on financial fraud of pharmaceutical listed companies[J]. Journal of Business Accounting, 2021(8): 99-101